WallStSmart
APGE

Apogee Therapeutics, Inc. Common Stock

NASDAQ: APGE · HEALTHCARE · BIOTECHNOLOGY

$82.03
-3.91% today

Updated 2026-04-29

Market cap
$6.39B
P/E ratio
P/S ratio
EPS (TTM)
$-4.22
Dividend yield
52W range
$34 – $95
Volume
0.9M

Apogee Therapeutics, Inc. Common Stock (APGE) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
-73.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+12.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+6.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+15.1%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-1.03-66.1%$74.94$74.68-0.3%
2025-11-10$-1.11-82.0%$54.71$62.95+15.1%
2025-08-11$-1.13-82.3%$35.39$36.70+3.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.62$-1.03-66.1%
2025-09-30$-0.61$-1.11-82.0%
2025-06-30$-0.62$-1.13-82.3%
2025-03-31$-0.58$-0.95-63.8%
2024-12-31$-0.62$-1.18-90.3%$130000.00
2024-09-30$-0.56$-0.86-54.1%
2024-06-30$-0.52$-0.60-15.4%
2024-03-31$-0.61$-0.64-4.9%
2023-12-31$-0.49$-0.32+34.7%
2023-09-30$-0.41$-0.51-24.4%
2023-06-30$-1.70$-3.78-122.4%
2023-03-31$0.00$-2.38

Frequently asked questions

Has Apogee Therapeutics, Inc. Common Stock beaten earnings estimates?
Apogee Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports, with an average EPS surprise of -73.5% over the last 4 quarters.
How does APGE stock react to earnings?
APGE stock has moved an average of +6.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.